Viewing Study NCT05456256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-27 @ 5:10 PM
Study NCT ID: NCT05456256
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2022-07-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Sponsor: Lantern Pharma Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of Lung View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None never smoker View
None non smoker View
None EGFR View
None ALK View
None ROS View
None MET View
None tyrosine kinase inhibitor View
None TKI View
None pemetrexed View
None carboplatin View
None NSCLC View
None never-smoker View
None non-smoker View
None TK inhibitor View
None lung cancer View